Automatisches Testsystem für Viruslasten und Screening
Originaltitel der Bekanntmachung
Italy – Reagents and contrast media – FORNITURA DI UN SISTEMA COMPLESSO PER TEST IN AUTOMAZIONE PER LE VIREMIE PRINCIPALI (HIV-HBV-HCV-CMV) E SCREENING BATTERIOLOGICO PER MRSA E GBS IN BIOLOGIA MOLECOLARE QUANTITATIVA E QUALITATIVA NECESS
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
50 / 100
Risikofaktoren
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Eckdaten der Ausschreibung
- Öffentlicher Auftraggeber
- AZIENDA USL DI BOLOGNA
- Land
- Italien
- CPV
- 33696000 - Reagents and contrast media
- Frist
- Jun 25, 2026
- Geschätzter Wert
- EUR 784.8k
Überblick
Moderate opportunityWichtige Fakten
- EUR 784.8k estimated value
- Supplies contract
- 1 lot
- Duration 1095 DAY
- Supply automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) using quantitative and qualitative molecular biology.
- System to be delivered to Azienda Ospedaliero Universitaria di Ferrara.
Vollständige Zusammenfassung anzeigen
Open tender for the supply of an automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) for the Microbiology Unit of Azienda Ospedaliero Universitaria di Ferrara. The buyer is Azienda USL di Bologna. Single lot, estimated value €784,790. Submission deadline 16 July 2026. Awarded on most economically advantageous basis (quality). Only notice data available; procurement documents not analyzed.
Risiken
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Automated system for molecular biology testing.
- System must handle viremia tests (HIV, HBV, HCV, CMV).
- System must handle bacteriological screening (MRSA, GBS).
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
Bologna, ITA
Auftraggeberprofil
Kennung
02406911202
Tätigkeit
Health
Lose (1)
LOT-0001
Sistema complesso per test viremie e screening batteriologico
Supply of an automated system for quantitative and qualitative molecular biology testing for HIV, HBV, HCV, CMV viremias and bacteriological screening for MRSA and GBS.
EUR 784.8k
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Offerta economicamente più vantaggiosa
Hinweis zum Wert
Originale TED-Daten anzeigen
Originale TED-Beschreibung
Sistema complesso per test viremie e screening batteriologico
Vergabedetails
- Veröffentlichungsdatum
- 07 Jun 2026
- Sprachen
- Italian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 390496-2026
Dokumente (2)
Ähnliche Ausschreibungen
Poland – Pharmaceutical products – Dostawa produktów farmaceutycznych i dietetycznych
Poland – Pharmaceutical products – produkty lecznicze w 309 pakietach dla potrzeb Apteki Szpitalnej Wojewódzkiego Szpitala Zespolonego w Elblągu
Portugal – Reagents and contrast media – Concurso Público Internacional nº 1070/2026 – Aquisição de testes para execução de exames de doseamento de drogas biológicas, hormonas esteróides e marcadores fecais, com colocação de equipamento em r
Latvia – Reagents and contrast media – Reaģenti, piederumi un aprīkojums molekulārai diagnostikai
Poland – Analysers – Przetarg nieograniczony PN/18DzOL/09/2026 na dostawy odczynników wraz z dzierżawą automatycznego systemu do izolacji kwasów nukleinowych
Lithuania – Reagents and contrast media – Reagentai ir eksploatacinės medžiagos (Nr. 10913-16)
Opportunity Score
Warum diese Bewertung?
Chance
65 / 100
Komplexität
50 / 100
Risikofaktoren
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications